Загрузка...
Once-monthly risedronate for postmenopausal osteoporosis
Bisphosphonates are the mainstay of treatment for postmenopausal women with osteoporosis. Despite numerous clinical trials documenting efficacy, tolerability, and safety of bisphosphonate therapy, long-term persistence and adherence to these agents remains low. This has serious consequences for pati...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2971711/ https://ncbi.nlm.nih.gov/pubmed/21072270 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|